PARP Inhibitors in Breast Cancer: a Short Communication Gordon R. DalyMaen Monketh AlRawashdehLeonie Young ReviewPaper Open access 02 January 2024 Pages: 103 - 113
Appendiceal Neuroendocrine Neoplasms: an Update for 2023 Pernille HolmagerSeppo W. LangerUlrich Knigge REVIEW 02 January 2024 Pages: 114 - 120
Sarcopenia and Neuroendocrine Neoplasms Dominique ClementSarah BrownRajaventhan Srirajaskanthan REVIEW 25 January 2024 Pages: 121 - 128
Prolymphocytic Leukaemia: an Update on Biology and Treatment Dima El-SharkawiClaire Dearden Review 02 January 2024 Pages: 129 - 135
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease Janina StumpfOthman Al-Sawaf REVIEW Open access 04 January 2024 Pages: 136 - 146
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival Catherine Powers-JamesMeroƫ MorseLorenzo Cohen ReviewPaper 05 January 2024 Pages: 147 - 163
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours Nina Fuller-ShavelJonathan Krell REVIEW Open access 09 January 2024 Pages: 164 - 174
Germline Mutations and Ancestry in Prostate Cancer Eudoxie BatabaKevin BabcockAlbert Dobi Review Open access 24 January 2024 Pages: 175 - 180
Elderly Rectal Cancer: An Updated Review Chih-Kai HuangChi-Hsiu ShihYung-Shuo Kao REVIEW 25 January 2024 Pages: 181 - 190